Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001827672-23-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-23 | 2023-03-21+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $12.55 | -2,125 | 8,597 | -20% | -$26.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-22 | S | D | 709 | $12.64 | 9,334 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-21 | S | D | 679 | $12.89 | 10,043 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-23 | S | D | 737 | $12.15 | 8,597 | D | — | — |